OGI
Organigram Global Inc.
Price Chart
Latest Quote
$0.96
| Previous Close | $0.96 |
| Open | $0.96 |
| Day High | $0.97 |
| Day Low | $0.95 |
| Volume | 12,050 |
Stock Information
| Shares Outstanding | 140.78M |
| Total Debt | $5.78M |
| Cash Equivalents | $3.60M |
| Revenue | $193.35M |
| Net Income | $-17.78M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $135.14M |
| EPS (TTM) | $-0.15 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $191.75M |
| Sales | $193.35M |
| Income | $-17.78M |
| Book/sh | $1.95 |
| Cash/sh | $0.04 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 0.66 |
| Current Ratio | 2.82 |
| Debt/Eq | 1.93 |
Returns & Margins
| ROA | -1.67% |
| ROE | -5.92% |
| Gross Margin | 35.63% |
| Operating Margin | -16.38% |
| Profit Margin | -9.20% |
Ownership
| Insider Ownership | 30.26% |
| Institutional Ownership | 6.70% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 43.64 |
| P/S | 0.49 |
| P/B | 0.49 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $1.06 |
| SMA50 | $1.22 |
| SMA200 | $1.52 |
| RSI | 24.00 |
| ATR | 0.0480 |
| Shares Float | 98.21M |
| Short Ratio | 6.97 |
| Volatility | 1.84 |
| Rel Volume | 0.02 |
Performance History
| Week | -6.80% |
| Month | -15.04% |
| Quarter | -29.41% |
| 6 Months | -52.71% |
| YTD | -44.51% |
| Year | -25.58% |
| 3 Years | -41.89% |
| 5 Years | -92.21% |
| 10 Years | -96.93% |
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.96 | 12,050 |
| 2026-06-22 | $0.96 | 390,400 |
| 2026-06-18 | $0.96 | 708,400 |
| 2026-06-17 | $0.99 | 493,100 |
| 2026-06-16 | $1.01 | 2,305,400 |
| 2026-06-15 | $1.03 | 1,073,400 |
| 2026-06-12 | $1.06 | 255,400 |
| 2026-06-11 | $1.08 | 379,800 |
| 2026-06-10 | $1.06 | 239,700 |
| 2026-06-09 | $1.08 | 796,400 |
| 2026-06-08 | $1.07 | 179,400 |
| 2026-06-05 | $1.06 | 688,700 |
| 2026-06-04 | $1.08 | 494,000 |
| 2026-06-03 | $1.06 | 297,500 |
| 2026-06-02 | $1.09 | 479,200 |
| 2026-06-01 | $1.13 | 459,700 |
| 2026-05-29 | $1.14 | 379,000 |
| 2026-05-28 | $1.14 | 833,600 |
| 2026-05-27 | $1.11 | 579,400 |
| 2026-05-26 | $1.11 | 331,000 |
About Organigram Global Inc.
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company is headquartered in Toronto, Canada.
đ° Latest News
Organigram Global Inc (OGI) Raises 2026 Guidance on Sanity Acquisition
Insider Monkey âĸ 2026-05-31T12:15:14ZWeekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive âĸ 2026-05-18T14:03:51ZOrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call Transcript
Benzinga âĸ 2026-05-13T09:11:10ZTranscript: OrganiGram Holdings Q2 2026 Earnings Conference Call
Benzinga âĸ 2026-05-13T09:10:54ZOrganigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ...
GuruFocus.com âĸ 2026-05-12T19:01:19ZCannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
InvestorsHub âĸ 2026-05-12T15:05:50ZOrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
Zacks âĸ 2026-05-12T13:15:01ZOrganigram Global Q2 Earnings Call Highlights
MarketBeat âĸ 2026-05-12T13:07:33ZOrganigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance
MT Newswires âĸ 2026-05-12T11:54:13ZViemed Healthcare, Inc. (VMD) Q1 Earnings Miss Estimates
Zacks âĸ 2026-05-06T00:30:14ZIncome Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $112,130,440 | $73,550,734 | $66,868,287 | $55,822,498 |
| Cost Of Revenue | $119,394,431 | $79,364,753 | $80,723,572 | $76,004,804 |
| Total Revenue | $183,142,310 | $112,945,872 | $103,030,666 | $55,937,676 |
| Operating Revenue | $284,682,021 | $174,590,162 | $147,678,065 | $77,485,160 |
| Expenses | ||||
| Total Expenses | $193,953,503 | $137,504,945 | $130,413,368 | $107,406,726 |
| Other Income Expense | $-16,413,934 | $-7,549,463 | $17,531,091 | $-38,796,636 |
| Other Non Operating Income Expenses | $-19,785 | $-537,733 | - | $-2,514,132 |
| Operating Expense | $74,559,072 | $58,140,192 | $49,689,796 | $31,401,922 |
| Selling And Marketing Expense | $21,973,572 | $14,026,993 | $11,913,510 | $11,169,446 |
| General And Administrative Expense | $39,414,217 | $33,477,953 | $29,927,925 | $21,667,609 |
| Interest Expense | - | - | $303,137 | $2,091,577 |
| Net Non Operating Interest Income Expense | - | - | $-303,137 | $-2,091,577 |
| Interest Expense Non Operating | - | - | $303,137 | $2,091,577 |
| Other Operating Expenses | - | - | $-108,819 | $-5,756,783 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Normalized Income | $-6,960,061 | $-28,830,554 | $-28,474,226 | $-54,350,621 |
| Net Income From Continuing And Discontinued Operation | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Total Operating Income As Reported | $-10,811,193 | $-24,559,073 | $-30,491,096 | $-64,881,288 |
| Net Income Common Stockholders | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Net Income | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Net Income Including Noncontrolling Interests | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Net Income Continuous Operations | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Pretax Income | $-27,225,127 | $-32,108,536 | $-10,154,748 | $-92,357,263 |
| Special Income Charges | $2,228,660 | $-163,934 | $-5,626,766 | $-17,533,211 |
| Earnings From Equity Interest | $0 | $-3,733,748 | $-963,821 | $-789,994 |
| Operating Income | $-10,811,193 | $-24,559,073 | $-27,382,702 | $-51,469,050 |
| Depreciation Amortization Depletion Income Statement | $5,437,394 | $2,721,170 | $3,744,347 | $1,746,043 |
| Depreciation And Amortization In Income Statement | $5,437,394 | $2,721,170 | $3,744,347 | $1,746,043 |
| Gross Profit | $63,747,880 | $33,581,119 | $22,307,094 | $-20,067,128 |
| Net Interest Income | - | - | $-303,137 | $-2,091,577 |
| Per Share | ||||
| Diluted EPS | $-0.14 | $-0.34 | $-0.13 | $-1.44 |
| Basic EPS | $-0.14 | $-0.34 | $-0.13 | $-1.44 |
| Other | ||||
| Tax Effect Of Unusual Items | $-5,859,156 | $0 | $113,253 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $18,284,341 | $-12,745,902 | $-10,746,891 | $-30,330,695 |
| Total Unusual Items | $-16,394,149 | $-3,277,982 | $18,494,912 | $-38,006,642 |
| Total Unusual Items Excluding Goodwill | $-16,394,149 | $-3,277,982 | $18,494,912 | $-38,006,642 |
| Reconciled Depreciation | $12,701,385 | $8,535,189 | $17,599,632 | $21,928,349 |
| EBITDA (Bullshit earnings) | $1,890,192 | $-16,023,883 | $7,748,021 | $-68,337,337 |
| EBIT | $-10,811,193 | $-24,559,073 | $-9,851,611 | $-90,265,686 |
| Diluted Average Shares | $90,216,341 | $67,335,994 | $54,571,027 | $45,244,475 |
| Basic Average Shares | $90,216,341 | $67,335,994 | $54,571,027 | $45,244,475 |
| Diluted NI Availto Com Stockholders | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Tax Provision | $-9,730,073 | $0 | $-62,182 | $0 |
| Gain On Sale Of Ppe | $-6,360 | $447,287 | $-4,649,519 | $-1,714,245 |
| Restructuring And Mergern Acquisition | $-2,235,020 | $611,221 | $-1,852,035 | $2,514,132 |
| Gain On Sale Of Security | $-18,622,809 | $-3,114,047 | $24,121,679 | $-20,473,431 |
| Research And Development | $7,733,889 | $7,914,076 | $4,212,832 | $2,575,608 |
| Selling General And Administration | $61,387,789 | $47,504,946 | $41,841,435 | $32,837,055 |
| Other Gand A | $20,415,489 | $18,152,911 | $18,082,956 | $13,474,420 |
| Salaries And Wages | $18,998,728 | $15,325,042 | $11,844,969 | $8,193,188 |
| Excise Taxes | $101,640,050 | $61,712,832 | $44,728,660 | $21,690,220 |
| Impairment Of Capital Assets | - | $0 | $2,999,576 | $7,655,455 |
| Other Special Charges | - | - | $-346,947 | $1,943,188 |
| Write Off | - | - | $176,653 | $3,706,190 |
Balance Sheet (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $175,307,376 | $210,498,161 | $319,261,586 | $326,991,942 |
| Total Assets | $397,266,107 | $288,199,545 | $407,791,828 | $391,476,113 |
| Total Non Current Assets | $195,953,927 | $102,911,955 | $251,189,936 | $207,321,931 |
| Non Current Deferred Assets | $2,652,629 | $417,609 | $3,912,521 | $2,257,631 |
| Investmentin Financial Assets | $35,011,306 | $28,778,264 | $0 | - |
| Goodwill And Other Intangible Assets | $71,392,735 | $5,717,920 | $39,739,259 | $12,044,941 |
| Other Intangible Assets | $34,278,547 | $5,717,920 | $10,076,314 | $1,925,523 |
| Current Assets | $201,312,180 | $185,287,590 | $156,601,892 | $184,154,182 |
| Restricted Cash | $39,142,170 | $18,273,035 | - | - |
| Prepaid Assets | $8,241,945 | $6,441,492 | $5,908,705 | $4,915,913 |
| Inventory | $87,587,619 | $58,312,605 | $48,249,010 | $34,495,477 |
| Receivables | $45,830,271 | $26,252,826 | $32,767,100 | $15,040,277 |
| Other Receivables | $120,124 | $929,197 | $770,916 | $448,700 |
| Taxes Receivable | $284,765 | $9,893 | $1,002,685 | $137,790 |
| Accounts Receivable | $44,930,045 | $23,074,477 | $30,993,499 | $14,277,134 |
| Allowance For Doubtful Accounts Receivable | $-4,029,819 | $-3,671,566 | $-792,114 | $-501,696 |
| Gross Accounts Receivable | $48,959,864 | $26,746,043 | $31,785,613 | $14,778,830 |
| Cash Cash Equivalents And Short Term Investments | $20,510,175 | $76,007,631 | $69,677,077 | $129,702,514 |
| Cash And Cash Equivalents | $19,926,512 | $75,427,501 | $48,413,651 | $39,121,679 |
| Cash Financial | $19,926,512 | $75,427,501 | $48,413,651 | $39,121,679 |
| Non Current Accounts Receivable | - | $32,504 | $551,865 | $766,676 |
| Other Non Current Assets | - | - | $18,951,385 | $21,982,052 |
| Loans Receivable | - | - | $0 | $176,653 |
| Receivables Adjustments Allowances | - | - | - | $0 |
| Debt | ||||
| Total Debt | $6,184,285 | $3,147,965 | $2,372,103 | $4,200,820 |
| Long Term Debt And Capital Lease Obligation | $5,474,844 | $2,380,582 | $1,668,315 | $3,448,982 |
| Current Debt And Capital Lease Obligation | $709,440 | $767,383 | $703,787 | $751,837 |
| Current Debt | $17,665 | $42,397 | $56,529 | $56,529 |
| Other Current Borrowings | $17,665 | $42,397 | $56,529 | $56,529 |
| Long Term Debt | - | $17,665 | $109,525 | $162,521 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $150,565,996 | $71,983,465 | $48,790,983 | $52,439,231 |
| Total Non Current Liabilities Net Minority Interest | $61,420,293 | $34,305,398 | $9,725,834 | $33,879,310 |
| Other Non Current Liabilities | $3,543,669 | - | $2,058,366 | $3,913,228 |
| Derivative Product Liabilities | $3,890,616 | $9,970,322 | $3,443,330 | $26,517,100 |
| Non Current Deferred Liabilities | $0 | $0 | $2,555,822 | $0 |
| Current Liabilities | $89,145,703 | $37,678,066 | $39,065,149 | $18,559,921 |
| Other Current Liabilities | $25,120,831 | $3,631,289 | $4,946,297 | $2,473,149 |
| Current Deferred Liabilities | $252,261 | $0 | $1,726,964 | - |
| Payables And Accrued Expenses | $63,063,171 | $33,279,395 | $29,879,169 | $13,391,747 |
| Payables | $63,063,171 | $33,279,395 | $29,879,169 | $13,391,747 |
| Accounts Payable | $63,063,171 | $33,279,395 | $28,875,070 | $13,391,747 |
| Total Tax Payable | - | $0 | $1,004,098 | $0 |
| Income Tax Payable | - | $0 | $1,004,098 | $0 |
| Non Current Deferred Taxes Liabilities | - | - | $2,555,822 | $0 |
| Equity | ||||
| Common Stock Equity | $246,700,111 | $216,216,081 | $359,000,845 | $339,036,882 |
| Total Equity Gross Minority Interest | $246,700,111 | $216,216,081 | $359,000,845 | $339,036,882 |
| Stockholders Equity | $246,700,111 | $216,216,081 | $359,000,845 | $339,036,882 |
| Gains Losses Not Affecting Retained Earnings | $26,815,291 | $26,191,351 | $19,968,909 | $17,415,206 |
| Other Equity Adjustments | $26,815,291 | $26,191,351 | $19,968,909 | $17,415,206 |
| Retained Earnings | $-430,134,960 | $-412,639,906 | $-204,866,448 | $-194,773,882 |
| Preferred Securities Outside Stock Equity | $48,511,164 | $21,954,494 | - | - |
| Long Term Equity Investment | - | $0 | $4,443,188 | $3,552,855 |
| Other Equity Interest | - | - | - | $17,470,322 |
| Other | ||||
| Ordinary Shares Number | $95,012,032 | $76,728,018 | $55,436,599 | $52,781,589 |
| Share Issued | $95,012,032 | $76,728,018 | $55,436,599 | $52,781,589 |
| Tangible Book Value | $175,307,376 | $210,498,161 | $319,261,586 | $326,991,942 |
| Invested Capital | $246,717,776 | $216,276,143 | $359,166,899 | $339,255,933 |
| Working Capital | $112,166,477 | $147,609,524 | $117,536,743 | $165,594,261 |
| Capital Lease Obligations | $6,166,620 | $3,087,903 | $2,206,049 | $3,981,769 |
| Total Capitalization | $246,700,111 | $216,233,746 | $359,110,370 | $339,199,403 |
| Capital Stock | $650,019,780 | $602,664,636 | $543,898,384 | $516,395,558 |
| Common Stock | $650,019,780 | $602,664,636 | $543,898,384 | $516,395,558 |
| Long Term Capital Lease Obligation | $5,474,844 | $2,362,917 | $1,558,790 | $3,286,461 |
| Current Capital Lease Obligation | $691,775 | $724,986 | $647,258 | $695,308 |
| Investments And Advances | $35,011,306 | $28,778,264 | $4,443,188 | $3,552,855 |
| Held To Maturity Securities | $27,892,170 | $22,130,441 | - | - |
| Available For Sale Securities | $7,119,135 | $6,647,824 | - | - |
| Goodwill | $37,114,188 | $0 | $29,662,945 | $10,119,418 |
| Net PPE | $86,897,258 | $67,998,162 | $183,591,717 | $166,717,777 |
| Accumulated Depreciation | $-191,126,341 | $-183,104,153 | $-58,181,882 | $-43,132,419 |
| Gross PPE | $278,023,598 | $251,102,316 | $241,773,599 | $209,850,196 |
| Leases | $7,880,158 | $392,171 | - | - |
| Other Properties | $150,929,196 | $132,355,143 | $127,763,566 | $109,560,485 |
| Buildings And Improvements | $115,889,626 | $115,030,383 | $103,356,415 | $95,932,023 |
| Land And Improvements | $3,324,618 | $3,324,618 | $3,324,618 | $2,879,452 |
| Other Inventories | $19,583,098 | $20,910,825 | $17,920,435 | $11,764,415 |
| Finished Goods | $13,236,292 | $6,553,844 | $6,051,441 | $5,507,349 |
| Work In Process | $42,529,677 | $24,231,910 | $17,693,612 | $12,967,778 |
| Raw Materials | $12,238,553 | $6,616,026 | $6,583,522 | $4,255,936 |
| Duefrom Related Parties Current | $495,336 | $2,239,259 | - | - |
| Other Short Term Investments | $583,663 | $580,130 | $21,263,425 | $90,580,836 |
| Other Investments | - | $32,504 | $551,865 | $766,676 |
| Investmentsin Associatesat Cost | - | $0 | $4,443,188 | $3,552,855 |
| Construction In Progress | - | $95,393 | $7,328,999 | $1,478,236 |
| Current Provisions | - | - | $1,808,932 | $1,943,188 |
Cash Flow Statement (Annual)
| Metric | 2025-09-30 | 2024-09-30 | 2022-08-31 | 2021-08-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-17,410,966 | $-1,035,896 | $-60,054,409 | $-28,889,203 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,363,906 | $2,736,009 | $-25,587,196 | $-20,201,385 |
| Cash Flow From Continuing Operating Activities | $-5,363,906 | $2,736,009 | $-25,587,196 | $-20,201,385 |
| Operating Gains Losses | $18,407,999 | $6,400,509 | $-18,508,338 | $22,977,671 |
| Investing Activities | ||||
| Capital Expenditure | $-12,047,060 | $-3,771,905 | $-34,467,213 | $-8,687,818 |
| Investing Cash Flow | $-57,282,362 | $-21,765,828 | $31,114,330 | $-81,337,619 |
| Cash Flow From Continuing Investing Activities | $-57,282,362 | $-21,765,828 | $31,114,330 | $-81,337,619 |
| Net Other Investing Changes | - | $-5,629,593 | $4,081,402 | $-21,429,480 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $29,099,067 | $76,709,298 | $0 | $201,297,341 |
| Financing Cash Flow | $27,793,245 | $76,158,140 | $3,764,839 | $123,277,981 |
| Cash Flow From Continuing Financing Activities | $27,793,245 | $76,158,140 | $3,764,839 | $123,277,981 |
| Net Common Stock Issuance | $29,099,067 | $76,709,298 | $0 | $201,297,341 |
| Common Stock Issuance | $29,099,067 | $76,709,298 | $0 | $201,297,341 |
| Net Other Financing Charges | - | - | $-60,062 | - |
| Cash Dividends Paid | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-1,308,649 | $-555,399 | $-715,800 | $-82,251,978 |
| End Cash Position | $59,068,682 | $93,700,536 | $48,413,651 | $39,121,679 |
| Beginning Cash Position | $93,700,536 | $36,572,216 | $39,121,679 | $17,382,702 |
| Effect Of Exchange Rate Changes | $221,170 | $0 | - | - |
| Changes In Cash | $-34,853,024 | $57,128,321 | $9,291,973 | $21,738,977 |
| Proceeds From Stock Option Exercised | $2,826 | $4,240 | $4,540,701 | $5,926,371 |
| Net Issuance Payments Of Debt | $-1,308,649 | $-555,399 | $-715,800 | $-82,251,978 |
| Net Long Term Debt Issuance | $-1,308,649 | $-555,399 | $-715,800 | $-82,251,978 |
| Long Term Debt Payments | $-1,308,649 | $-555,399 | $-715,800 | $-82,251,978 |
| Net Investment Purchase And Sale | $1,053,561 | $-18,175,523 | $69,317,410 | $-49,426,229 |
| Sale Of Investment | $1,765,122 | $2,485,868 | $79,916,619 | $35,381,571 |
| Purchase Of Investment | $-711,560 | $-20,661,390 | $-10,599,208 | $-84,807,800 |
| Net Business Purchase And Sale | $-46,368,004 | $0 | $-7,817,270 | $-1,794,093 |
| Purchase Of Business | $-46,368,004 | $0 | $-7,817,270 | $-1,794,093 |
| Net Intangibles Purchase And Sale | $-19,079 | $-428,915 | $-21,198 | $-380,158 |
| Purchase Of Intangibles | $-19,079 | $-428,915 | $-21,198 | $-380,158 |
| Net PPE Purchase And Sale | $-11,948,841 | $-3,161,391 | $-34,446,014 | $-8,307,660 |
| Sale Of PPE | $79,141 | $181,600 | $0 | $24,025 |
| Purchase Of PPE | $-12,027,982 | $-3,342,990 | $-34,446,014 | $-8,307,660 |
| Change In Working Capital | $-1,500,141 | $10,568,824 | $-16,165,206 | $10,216,930 |
| Change In Payables And Accrued Expense | $9,301,865 | $19,089,881 | $10,443,047 | $1,457,038 |
| Change In Receivables | $-10,802,007 | $-8,521,057 | $-26,608,253 | $-4,244,630 |
| Other Non Cash Items | $-10,921,424 | $1,281,798 | $-4,938,525 | $7,428,632 |
| Stock Based Compensation | $2,979,791 | $5,074,901 | $3,622,809 | $2,752,968 |
| Asset Impairment Charge | $193,612 | $2,983,324 | $3,176,229 | $4,908,140 |
| Deferred Tax | $-9,730,073 | $0 | $-62,182 | $0 |
| Deferred Income Tax | $-9,730,073 | $0 | $-62,182 | $0 |
| Depreciation Amortization Depletion | $12,701,385 | $8,535,189 | $17,599,632 | $21,928,349 |
| Depreciation And Amortization | $12,701,385 | $8,535,189 | $17,599,632 | $21,928,349 |
| Amortization Cash Flow | $4,284,907 | $2,218,061 | $1,869,700 | - |
| Amortization Of Intangibles | $4,284,907 | $2,218,061 | $1,869,700 | - |
| Depreciation | $8,416,478 | $6,317,128 | $15,729,932 | - |
| Earnings Losses From Equity Investments | $0 | $3,733,748 | $963,821 | $789,994 |
| Gain Loss On Investment Securities | $18,622,809 | $3,114,047 | $-24,121,679 | $20,473,431 |
| Net Foreign Currency Exchange Gain Loss | $-221,170 | $0 | - | - |
| Gain Loss On Sale Of PPE | $6,360 | $-447,287 | $4,649,519 | $1,714,245 |
| Net Income From Continuing Operations | $-17,495,054 | $-32,108,536 | $-10,092,566 | $-92,357,263 |
| Interest Paid Cff | - | - | $0 | $-1,693,754 |
| Change In Other Working Capital | - | - | $84,794 | $-382,985 |
| Change In Other Current Liabilities | - | - | $1,774,308 | $0 |
| Change In Prepaid Assets | - | - | $-1,001,979 | $-382,985 |
| Change In Inventory | - | - | $-8,633,409 | $13,387,507 |
| Changes In Account Receivables | - | - | $-16,972,866 | $-4,244,630 |
| Provisionand Write Offof Assets | - | - | $-219,050 | $1,943,188 |
| Issuance Of Debt | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Change In Payable | - | - | - | $1,457,038 |
| Change In Account Payable | - | - | - | $1,457,038 |